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ABSTRAK 
PERILAKU KLINIKAL PESAKIT DENGAN POSITIF  
CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE) DAN GENOTIP 
 
Pengenalan 
Carbapenem-resistant Enterobacteriaceae (CRE) adalah mikroorganisma yang sedang 
muncul dan berkembang di seluruh dunia dan bakal menimbulkan ancaman kepada tatacara 
penjagaan kesihatan. Gen yang boleh dipindah milik telah menyebabkan kerintangan kepada 
banyak kumpulan antibiotik yang membawa kepada kesukaran rawatan dan kadar kematian 
yang tinggi. CRE adalah biasanya berkaitan dengan penjagaan kesihatan. 
Jangkitan invasif dengan CRE telah dikaitkan dengan kes kematian yang tinggi. Mengenal 
pasti pesakit dengan CRE positif adalah penting untuk menghalang penyebaran organisma 
berdaya tahan ini yang berpotensi untuk menyebabkan jangkitan. Oleh yang demikian, kajian 
ini dijalankan untuk mengetahui signifikasi dan gen bagi CRE berserta perilaku klinikal 
setiap pesakit yang positif CRE di HUSM. 
 
Tatacara kajian 
Kajian ini dijalankan di Hospital Universiti Sains Malaysia bermula Ogos 2013 sehingga 
Disember 2015. CRE positif telah dikenal pasti daripada Makmal Mikrobiologi Perubatan & 
Parasitologi. CRE yang telah di kenalpasti kemudian diuji untuk gen bla-NDM. Semua yang 
negatif bla-NDM kemudiannya akan diuji untuk gen bla-IMP  menggunakan teknik PCR. Rekod 
pesakit di semak dan kemudiannya data yang dikumpulkan dianalisa menggunakan perisian 
SPSS Statistik versi 22. Analisa secara deskriptif dijalankan bagi kedua-dua kategori dan  
xvi 
 
pemboleh ubah bebas berangka dan seterusnya diukur menggunakan frekuensi, peratusan dan 
median interquatile range (IQR) secara respektif. Bagi kategori analisa data, Fisher exact test 
and Pearson Chi-square test digunakan.  
 
Keputusan 
Antara 136 CRE sampel daripada 114 pesakit, 60 (44.1%) adalah daripada sapuan rektum 
diikuti oleh urin [25 (18.4%)], cecair badan [19 (14.0%)], darah [15 (11.0%)], kahak [9 
(6.6%)] dan sapuan /tisu [8 (5.9%)]. Organisma yang paling banyak adalah Klebsiella 
pneumoniae (n= 126, 92.7%), diikuti oleh Enterobacter aerogenes (n=4, 2.9%), Enterobacter 
cloacae dan Klebsiella ozanae  [dua (1.5%)]. Satu  (0.7%) sampel adalah Citrobacter freundii 
dan Escherichia coli. Genotip yang paling banyak adalah bla-NDM1 (n=112, 82.4%) dan hanya 
satu (0.7%) bla-IMP. Kebanyakan daripada pesakit, 81(71.1%) telah dikoloni oleh CRE, 23 
(20.2%) telah dijangkiti dan sepuluh (8.8%) pesakit adalah telah dikoloni  dan kemudiannya 
dijangkiti. CRE kebanyakannya terjadi di kalangan pesakit yang sudah mempunyai penyakit 
lain sebelum ini (n=89, 78.1%). Darah tinggi (53.5%), kencing manis (43.9%) dan penyakit 
buah pinggang kronik (36.0%) adalah merupakan penyakit yang paling banyak ditemui.  
Kebanyakan pesakit mempunyai kemasukan ke hospital secara berpanjangan (n=90, 78.9%), 
kemasukan ke ICU (n=69, 60.5%) dan sejarah kemasukan ke hospital (n=70, 61.4%) semasa 
CRE di kesan. Jangkitan yang kerapkali berlaku adalah jangkitan saluran darah (n=14, 
35.0%) dan pneumonia (n=14, 35.0%). CRE-Jangkitan saluran darah (p=0.002) dan CRE-
pneumonia (p<0.001) adalah sangat berkait dengan kematian. 
 
 
 
xvii 
 
Kesimpulan 
Hasil daripada kajian yang telah dijalankan, adalah didapati kebanyakan daripada sampel 
CRE adalah Klebsiella pneumoniae dan kebanyakannya daripada pesakit yang telah di koloni 
CRE. Gen bla-NDM adalah gen yang paling banyak dikesan dalam sampel CRE. Lebih 50% 
daripada pesakit yang positif CRE adalah terdiri daripada mereka yang telah dimasukkan ke 
hospital secara berpanjangan, kemasukan ke ICU dan pernah dimasukkan ke hospital. 
Sebagai tambahan, CRE-jangkitan saluran darah and CRE-pneumonia adalah jangkitan yang 
paling banyak ditemui dan kebiasaannya mengakibatkan kematian.    
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CHAPTER 1  
 INTRODUCTION 
 
1.1 Overview of Carbapenem Resistant Enterobacteriaceae (CRE) 
     
Carbapenem Resistant Enterobacteriaceae (CRE) has emerged globally and effective 
infection control measures are important to prevent further spread. These Enterobacteriaceae 
which normally resides in human gastrointestinal tract are now become more virulence and 
causing harmful diseases to human mainly those staying in hospital and possibility in 
community as well. Early detection of these organism and early recognition of the patients at 
risk of getting this ‘super bug’ is necessary. CRE is associated with higher mortality (40%) 
compared to carbapenem sensitive Enterobactericeae (Hussein et al., 2013).  
Carbapenem that previously work as a miracle drug for Gram negative organisms are no 
longer able to fight them and leading to the use of old drugs such as Polymyxin which was 
first found in 1947 (Storm et al., 1947). It was abandoned and not actively used for years due 
to its neurotoxic and nephrotoxic effect (Evans et al., 1999).  
There are few complex mechanisms of resistance in CRE which include production of 
carbapenemase enzymes labelled as Carbapenemase Producer - Carbapenem Resistant 
Enterobacteriaceae (CP-CRE). The resistant genes are located in the plasmid that easily 
transferable from one species to another. CP-CRE is important to be recognized as it will 
determine the choice of therapeutic management and extent of infection control measures that 
need to be implemented.  
Metallo-beta-lactamase enzymes are the most predominant cause of CRE in Malaysia which 
causes resistant not only to carbapenem but to other beta-lactam drug. Detection of these 
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enzymes possess difficulty in the laboratory as the current use of phenotypic detection of 
carbapenemases which is the Modified Hodge test has lower sensitivity to detect Metallo-
beta lactamase compared to other enzymes such as serine beta-lactamase (eg: KPC gene) 
which has better detection.  
Molecular methods in detecting gene responsible for CRE are now better option for 
carbapenemase gene detection particularly in the reference laboratory. It provides accurate, 
reliable and fast results which is necessary for treatment and infection control measures. 
1.2 Rationale of the Study 
CRE is one of the national surveillance organisms under Infection Control Unit, Medical 
Development Division in Ministry Of Health, Malaysia. Based on the national surveillance 
data in 2015, incidence for CRE was increasing from 0.02 per 100 admissions in 2013 to 0.05 
per 100 admissions in 2015. Although the rate was still low compared to other national 
surveillance organisms, the devastating effect and the possible of rapid spread of these 
organisms warrant continuous attention to these organisms. Furthermore reported prevalence 
of CRE was increasing worldwide. As in US, CDC in March 2013 reported that 3.9% of short 
stay acute care hospital and 17.8% of long term acute care hospitals reported at least one 
CRE health care associated infection.  
Infection prevention control strategies and attention to colonization pressure will be key 
factors in minimizing the spread of CRE infection or colonization (G.Bushnell et al., 2013). 
Patients colonized with CRE are thought to be a source of transmission in healthcare settings. 
Based on CDC guidelines 2012, recognizing CRE colonized or infected patients and place on 
contact precautions are one of the prevention strategies for CRE. Therefore we want to 
determine the clinical characteristics of patient with CRE in our settings as well as the burden 
of CRE infection and colonization in our settings. By knowing this, infection control 
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measures can be taken earlier as screening among patient who had higher risk can be done 
earlier. 
To date, NDM-1 gene was the commonest gene detected in CRE cases in Malaysia. Based on 
previous report done in HUSM, besides NDM-1 gene, bla-IMP4 gene was also detected in 
1.87% of the cases (Hamzan et al., 2015). However that study only involved small number of 
confirmed CRE cases (13 cases) and our study was done with a bigger number of sample 
size. The proportion of bla-NDM-1 gene and bla-IMP4 also can be determined in our settings in 
order to have a better representative distribution of the population. 
Based on this study, we were able to determine the type of infection that contributes to higher 
mortality among CRE patients. CRE-bloodstream infections were associated with high 
mortality rate (41.6%) (Tumbarello et al., 2012). Therefore it is to alert the management team 
regarding the higher risk of mortality in certain type of infection where CRE is isolated and 
prompt a judicious antibiotic usage including antimicrobial combining regime.     
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1    Enterobacteriaceae 
Enterobacteriaceae are Gram negative bacilli that are non-spore forming, facultative 
anaerobes that ferment glucose and other sugars, reduce nitrate to nitrite, produce catalase 
and do not produce oxidase except for Plesiomonas. Most are motile via peritrichous flagella 
except for Klebsiella spp and Shigella spp. These organism are the most commonly 
encountered organism in the laboratory from the clinical samples and mostly pathogenic 
(Farmer, 1995). Listed below are the hierarchy taxonomy of Enterobacteriaceae.  
Domain : Bacteria 
Phylum : Proteobacteria 
Class : Gammaproteobacteria 
Order : Enterobacteriales 
Family : Enterobacteriaceae 
There are 53 genera and over 170 named species of bacterial family Enterobacteriaceae and 
in which 26 of them are medically important and known to cause human infections. The 
genera keep on changing with the use of DNA sequencing on further identification of the 
genera and species (Nhung et al., 2007). Members of family Enterobacteriaceae are  
Arsenophonus, Biostraticola, Brenneria, Buchnera, Budvicia, Buttiauxella, 
Calymmatobacterium, Cedecea, Citrobacter, Cosenzaea, Cronobacter, Dickeya, 
Edwardsiella, Enterobacter, Erwinia, Escherichia, Ewingella, Gibbsiella, Hafnia, Klebsiella, 
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Kluyvera, Leclercia, Leminorella, Levinea, Lonsdalea, Mangrovibacter, Moellerella, 
Morganella, Obesumbacterium, Pantoea, Pectobacterium, Phaseolibacter, Photorhabdus, 
Plesiomonas, Pragia, Proteus, Providencia, Rahnella, Raoultella, Saccharobacter, 
Salmonella, Samsonia, Serratia, Shigella, Shimwellia, Sodalis, Tatumella, Thorsellia, 
Trabulsiella, Wigglesworthia, Xenorhabdus, Yersinia and Yokenella. Out of this, the 
medically important genera are Citrobacter, Edwarsiella, Enterobacter, Escherichia, Hafnia, 
Klebsiella, Morganella, Pantoea, Plesiomonas, Proteus, Providencia, Salmonella, Shigella, 
Serratia and Yersinia.  
 
2.2    Epidemiology of Enterobacteriaceae 
Enterobacteriaceae are widely distributed in the environment such as in soil and water. 
Besides that members of Enterobacteriaceae were also predominantly found in the lower 
gastrointestinal tract of various animals. Enterobacteriaceae were also found to be colonizing 
at oropharyngeal airways particularly in patients who had artificial ventilation either by 
endotracheal intubation or tracheostomy. More than 50% of similar microorganism were 
detected in lower respiratory tract sample, leading to 30% of the cases become infection  
(Van Uffelen et al., 1984). Members of Enterobacteriaceae causes wide variety of infections 
include hospital and community setting. They can affect both inpatient who had pre-existing 
illness or healthy people due to their virulence. They can be isolated from any clinical 
samples for examples urine, blood, sterile body fluids and specimen from respiratory tract. 
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2.3     Structure of Enterobacteriaceae 
Generally members of Enterobacteriaceae are rod shaped organisms, 1 to 3µm in length and 
0.5μm in diameter. Genomic construction comprises of single circular chromosomes and may 
include multiple plasmids of various sizes in the cytoplasm. It has both inner and outer 
membrane whereby in between were periplasmic space that contains peptidoglycan cell layer. 
The inner membrane is impervious to polar molecules, regulates the passage of nutrients, 
metabolites, macromolecules and information in and out of the cytoplasm and maintain the 
proton required for energy storage. Periplasmic space is an aqueous environment with high 
concentration of proteins and peptidoglycans. All types of proteins involve in biogenesis of 
peptidoglycans, capsules and lipopolysaccharide are available in this space. Peptidoglycan 
cell layer in Gram negative bacteria is only a thin layer as opposed to Gram positive bacteria 
who had a thick layer of peptidoglycan. This peptidoglycan is composed of alternating N-
acetylglucosamine and N-acetylmuramic acid amino sugars joined with short peptide. It is 
responsible for the shape and osmotic stability of the Gram negative organism.      
The outer membrane of Gram negative bacteria is composed of asymmetrical lipid bilayer. 
The inner leaflet is composed of phospholipid where else in the outer leaflet mainly made of 
lipopolysaccharide (LPS). Porin proteins are present through the outer membrane as a 
passage for hydrophilic molecules. Lipopolysaccharides consist of Lipid A, core 
oligosaccharides and O antigen (Raetz and Whitfield, 2002).  The O antigen is the basis for 
serogroup classifications. Flagella are flexible surface appandages that in charge to rotate and 
drive forward the bacteria in the liquid environment. H- antigen types that is present on the 
flagellin is responsible for one of the serotyping. Most Enterobacteriaceae had pili that 
extend from the surface and are thinner than flagella. Pili is important in adhesions to host 
cells, in autoaggregation and genetic exchange through conjugations. Besides that 
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Enterobacteriaceae also possess capsule that both link to LPS or α-glycerol phosphate and 
form the basis of K-antigen serotyping.  
 
2.4     Pathogenesis of Enterobacteriaceae causing infections 
Lipid A, also known as endotoxin which serves as the backbone of the LPS, is one of the 
pathogen-associated molecular patterns (PAMP) that can be recognized by pattern-
recognition receptors such as Toll-like receptor 4. It triggers the innate immune response in 
host cells. Other PAMP that can trigger the innate immune response would be flaggelin (a 
protein that is present in bacteria flagella) and  unmethylated CpG dinucleotides that is 
numerous in bacterial genomic DNA, both were present in Gram positive and Gram negative 
bacteria (Matsuura, 2013). However, LPS is only found in Gram negative bacteria.  These 
Toll-like receptors are express on the monocytes and macrophages. It will activates 
phagocytic activity and release of pro-inflammatory cytokines such as Tumor necrosis factor-
alpha (TNF-α), Interleukin-6 and other high inflammatory cytokines to kill the pathogens. 
However, excessive and prolonged uncontrolled activation of immune systems, particularly 
excessive TNF-α causes pathological effects characterized by endotoxic shock (Rosenfeld 
and Shai, 2006). 
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2.5     Infection with Enterobacteriaceae 
Enterobacteriaceae can cause wide variety of infections include healthcare associated 
infections and community acquired infections. There are few types of healthcare associated 
infections which include central line associated blood stream infection, ventilator associated 
pneumonia, catheter associated urinary tract infection and surgical site infection which will 
be discussed further below. Escherichia coli 0157: H7 is well known to cause hemorrhagic 
colitis (90% of cases) and haemolytic uremic syndrome (10% of cases) in human (Tarr, 
1995). Besides that Escherichia coli were also known to cause  urinary tract infection which 
is the commonest cause of extra intestinal infection due to the presence of α-hemolysins, P-
fimbriae and also Shiga toxins (Johnson and Russo, 2002; Toval et al., 2014). Proteus 
mirabilis and Providencia stuartii is the leading cause of catheter associated urinary tract 
infection and merely due to ability to form urease- dependant manner which co-infection can 
further promote urolithiasis and bacteraemia (Armbruster et al., 2014). The organism also 
able to form biofilm that promote colonization on the catheter (Jacobsen and Shirtliff, 2011). 
Klebsiella species is found higher in rectal carriage of patients being hospitalized rather than 
not hospitalized (Montgomerie, 1979). It is mainly due to usage of antibiotics that alter 
normal bowel flora rather than admission to hospital or immunosuppressive therapy 
(Montgomerie et al., 1970).  Besides colonization at the nose and pharynx which can lead to 
lower respiratory tract infection, Klebsiella species also can present on skin of normal healthy 
subject which later on can cause skin and soft tissue infections in the presence of wound 
(Marples, 1965). Bacteraemia and intrabdominal infections are other clinical manifestation of 
Enterobacteriaceae.  
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2.5.1 Health Care Associated Infection (HAI) 
Based on Centers for Disease Control (CDC) guideline 2016, HAI was defined as an 
infection where the date of event of site specific infection criterion occurs on or after the 3rd 
calendar day of admission to an inpatient location where day of admission is consider as day 
one. HAI can be further divided as central line associated bloodstream infection, surgical site 
infection, ventilator associated pneumonia and catheter associated urinary tract infection.              
Bloodstream infection is defined by the presence of pathogenic organism in the blood culture 
that is regard as infection, not contamination (Shah et al., 2013). It can be further divided into 
primary bloodstream infection or secondary bloodstream infection. Primary bloodstream 
infection is laboratory confirmed bloodstream infection and whereby the recovery of the 
pathogen is not secondary to an infection at other sites (CDC, 2016). Secondary bloodstream 
infection is defined when there is matching organism between blood culture and site specific 
infection or the positive blood culture is occurring within the infection period for the site 
specific infections (CDC, 2016).  
Central line associated bloodstream infection (CLABSI) is laboratory confirmed blood stream 
infection where by central line or umbilical catheter is presence for more than 2 days on the 
date of event, with day one is consider when the day of device placement took place and the 
line was also in place on the infectious date or the day before (CDC, 2016). CLABSI has 
different meaning and purpose compare to catheter related bloodstream infection (CRBSI). A 
CRBSI is regard as clinical definition, used when diagnosing and treating patients, which 
needs specific laboratory testing that can identifies the catheter as the source of the 
bloodstream infections (CDC, 2011). CRBSI is used for research investigations of the risk 
factors and pathogenesis of vascular catheter related bloodstream infections where else 
CLABSI is used for surveillance purposes and not related to research  (Shah et al., 2013).   
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Catheter associated urinary tract infection (CAUTI) is defined as presence of UTI where an 
indwelling urinary catheter was in position for more than 2 days and that indwelling urinary 
catheter was in place on the date of event or the day before (CDC, 2016). Indwelling catheter 
is a drainage tube (Foley catheters) that is introduced into the urinary bladder through the 
urethra, is left in place, and connected to a drainage bag. Condom, in-and-out catheters and 
nephrostomy tubes are not considered as indwelling catheter. Suprapubic catheters is not 
indwelling catheter too unless a Foley catheter is also present (CDC, 2016). Symptomatic 
urinary tract infection is defined as presence of positive urine culture with no more than 2 
organisms and at least one of the bacteria should have more than 105 colony forming unit per 
ml and there is presence at least one of the symptoms either fever (more than 38°C), 
frequency, urgency, dysuria, costovertebral angle pain and suprapubic tenderness in which 
there is no other recognized cause present (CDC, 2016). Prolonged catheterization and female 
due to short urethra were commonly seen as risk factors for developing CAUTI (Tambyah, 
2004). 
Pneumonia is defined based on collaborative of clinical, imaging and laboratory criteria. 
Pneumonia is presence of new lung infiltrate plus clinical evidence that the infiltrate is of an 
infectious origin, which include new onset of fever, purulent sputum, leukocytosis, and 
reduce in oxygenation (Mandell et al., 2007). It can be further divided into community 
acquired pneumonia (CAP), hospital acquired pneumonia (HAP) and ventilator associated 
pneumonia (VAP). For HAP, it is defined whereby pneumonia that occur after 48 hours of 
admission and not incubating at the time of admissions. VAP is defined as pneumonia that 
occur after 48 hours of endotracheal intubation (Kalil et al., 2016). Mortality rates for VAP 
was 38% (Tejerina et al., 2006). VAP was associated with prolonged ICU stay, hospital stay, 
and mechanical ventilation(Muscedere et al., 2010).  
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Surgical site infection (SSI) is defined as infections that occur up to 30 days of surgery or up 
to one year in patients receiving implant (Owens and Stoessel, 2008). Patient also should 
have at least one of these criteria which are; purulent discharge from incisional site, 
organisms able to be identified from aseptic specimen taken, or when culture is not 
performed patient had sign and symptoms of inflammation or diagnosis of SSI were made by 
surgeon or attending physicians (CDC, 2016). In US, SSI rate was 1.9% in 2006-2008 and 
mortality rate for SSI was 3% (CDC, 2016). The risk factors would be advanced age, 
underlying comorbidity, longer duration of surgery and complexity of surgery (Korol et al., 
2013). The most common site of surgery SSI being identified was colon surgery (32.3%) and 
most common organisms were Escherichia coli (20.4%), Pseudomonas aeruginosa (19.3%) 
and Candida albicans (13.7%) (Ballus et al., 2015).        
  
2.6 Treatment for Enterobacteriaceae 
Generally Enterobacteriaceae are sensitive to β-lactam drugs such as cephalosporin group, 
especially the third generation of cephalosporin such as cefotaxime, ceftriaxone and 
ceftazidime that have more stable activity for β-lactamases. However, TEM-1 and SHV-gene 
were commonly present in Enterobacteriaceae and confer resistance to ampicillin, 
amoxicillin, other penicillin group and earlier generation of cephalosporin but were still 
sensitive to third generation cephalosporins and monobactam. Nowadays the gene become 
mutated and produce Extended spectrum of beta-lactamases (ESBL) that are able to 
hydrolyse even third generation cephalosporin and monobactam (Paterson, 2006). There are 
other resistance genes in ESBL such as CTX-M and OXA-type ESBLs. For CTX-M type 
ESBL, higher MIC was seen with cefotaxime than ceftazidime (Walther-Rasmussen and 
Høiby, 2004). OXA-type ESBL more commonly seen in Acinetobacter species and 
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Pseudomonas aeruginosa and rarely in Enterobacteriaceae (Bonomo and Szabo, 2006). 
Carbapenem is the treatment of choice for ESBL bacteraemia (Vardakas et al., 2012). 
Previous usage of carbapenem is one of the risk factors for CRE (Hussein et al., 2009a) 
 
2.7       Carbapenem 
The backbone of carbapenem is thienamycin which is from Streptomyces cattleya. 
Thienamycin has high affinity to penicillin binding protein and stable against β-lactamases. 
However this thienamycin is not stable in aqueous environment and in mild base hydrolysis 
(Papp-Wallace et al., 2011). Carbapenem is a broad spectrum antimicrobial that has activity 
against Gram positive and Gram negative bacteria as well as anaerobic organisms including 
resistant to Extended spectrum beta-lactamases (ESBL) and Amp C- β lactamases (Zhanel et 
al., 2005). Carbapenem bind to penicillin-binding proteins (PBPs), prevent cross-linking of 
peptidoglycan and disturbing the growth and structural integrity of bacterial cell walls 
(Nicolau, 2008).  
Imipinem is the first carbapenem derivatives of thienamycin and is slightly more active 
against Gram positive organisms (Nicolau, 2008). However imipinem is subjected to 
hydrolysed by dehydropeptidase  I (DHP-I), found in the human renal brush border (Graham 
et al., 1987). It need to be co- administer with DHP-I inhibitor which is cilastatin (Norrby et 
al., 1983). This co-administration with cilastatin is important to prevent imipinem from 
destruction by dehydropeptidase. Imipinem has increased incidence of seizures (Zhanel et al., 
1998).  
Further modification of the structural composition of the carbapenem leads to release of 
meropenem, ertapenem and doripenem which is more stable and not destructed by DHP-I. 
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Imipinem has slightly more activity against Gram positive organism where else meropenem 
has slightly more activity against Gram negative organism (Nicolau, 2008). Ertapenem has 
limited activity for non-fermenting Gram negative bacteria where else doripenem has more 
activity against Pseudomonas aeruginosa (Nicolau, 2008). Both imipinem and meropenem 
has short half- life and require multiple dosing where else ertapenem possess a longer serum 
half-life and only needs once daily dosing (Zhanel et al., 2007).  
Carbapenem enter Gram negative bacteria through porins. Once in the periplasmic space, 
carbapenem permanently acylate Penicillin binding proteins (PBPs). Penicillin binding 
proteins were enzymes that catalyze the formation of peptidoglycan in the cell wall bacteria. 
When carbapenem binds to PBPs it inhibits peptide cross linking as well other peptidase 
reaction and causes weakening of the peptidoglycan thus cell lysis due to osmotic pressure 
(Papp-Wallace et al., 2011). Carbapenem have the ability to bind at multiple PBPs, renders 
them to become more efficacy (Hashizume et al., 1984)   
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2.8 Definition of CRE 
CDC previously in 2012 CRE Toolkit defines CRE as Enterobacteriaceae that is non-
susceptible to imipinem, meropenem or doripenem and resistant to all third generation 
cephalosporin. However this definition was difficult to implement due to multiple 
antimicrobials included in the definition and also the different criteria used for carbapenem 
(nonsusceptible) and cephalosporin (resistant).  
In January 2015, CDC has changed the CRE definition to Enterobacteriaceae which is 
resistant to imipinem, meropenem, doripenem or ertapenem or documentation of isolate 
possesses carbapenemase. Pre-2015 CDC CRE definition has misclassified 13% of 
carbapenem nonsusceptible Klebsiella spp, and 21% KPC-producing Klebsiella spp, as non-
CP-CRE (Chea et al., 2015). Addition of Modified Hodge Test (MHT) to the new CDC CRE 
definition 2015 has reduce false positive from 55% to 12% and were helpful in areas of low 
CRE prevalence and when dealing with organisms that were less likely to produce 
carbapenemase such as Escherichia coli or Enterobacter spp (Chea et al., 2015).  
Furthermore, some of the KPC-producing CRE strain only had resistant to ertapenem while 
remain susceptible to imipinem and meropenem (Arnold et al., 2011). This probably due to 
the presence of heterogenicity among isolates giving presence of susceptible in vitro and 
additional influences such as reduced outer membrane permeability is needed for KPC-
producing CRE  to possess full carbapenem resistant (Woodford et al., 2004). 
OXA-48 type carbapenemase also had been documented to remain susceptible against third 
generation cephalosporin and might be missed using previous definition (Poirel et al., 2012). 
Non-susceptible to cephalosporin which has been included in 2012 CRE definition, does not 
improve the ability to differentiate between CP-CRE and non-CP-CRE.  
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Acceptable methods for carbapenemase detection by CDC are polymerase chain reaction 
(PCR), MHT, Carba-NP test or metallo-β-lactamase testing. Addition of ertapenem in new 
guidelines for CDC CRE-definition November 2015 increases the detection of CP-CRE and 
non-CP- CRE strain (CDC, 2015). Ertapenem was the most sensitive indicator for detecting 
KPC-producing strain compare to meropenem or imipinem (Anderson et al., 2007).          
 
2.9 Epidemiology of CRE 
 It is important to acknowledge CRE as one of the worrisome organisms that has spread 
throughout the world. Prevalence rate of CRE in Asia  was still low with resistance rate of 
0.8% for imipinem and 1.0% for meropenem were seen in year of 2001-2012 (Xu et al., 
2015). However, this could be due to only 19 out of 49 Asia countries provide epidemiology 
data on CRE and an incline trend of CRE rate were seen during 2009 (1.2%) and 2012 (1.3%) 
(Xu et al., 2015). Based on National Alert Organism Surveillance 2015, CRE incidence rate 
in Malaysia was 0.05 of total isolates per 100 admissions. This was higher compared to 2014 
whereby the incidence rate was 0.03 of total isolates per 100 admissions.   
Klebsiella spp (39.26%) was the most common pathogens of CRE in Asia followed by 
Escherichia coli (21.97%), Serratia spp (19.8%), Enterobacter (12.97%), Proteus (3.95%) 
and Citrobacter (2.0%). Klebsiella pneumoniae was the most common pathogen causing 
CRE and this was supported by various study done in Singapore (Ling et al., 2015), Taiwan 
(Tang et al., 2016), and US (Guh et al., 2015). Different pathogens were seen in Korea 
whereby the most common organisms seen were Enterobacter aerogenes (31.7%) followed 
by Klebsiella pneumoniae (19.5%) (Lee et al., 2016a). Similarly in Greek, Enterobacter spp 
(49.0%) followed by Klebsiella pneumoniae (44.0%) was the most common CRE isolated 
(Miller and Johnson, 2016).  
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Carbapenem resistant Enterobacteriaceae were mostly detected in hospital settings but 
Enterobacteriaceae were common causes of community associated infections leading to 
probability of dissemination of CRE to community. Although CRE were commonly acquired 
in healthcare settings (70.5%) but community acquired CRE were seen in 29.5% of cases in 
Taiwan (Tang et al., 2016). The clinical presentation of CRE from community was different 
from CRE acquired in healthcare settings whereby the community-acquired CRE were 
commonly among elderly female with urinary tract infections compared to healthcare-
acquired CRE which were associated with intraabdominal infection, intrabdominal surgery 
and presence of indwelling devices (Tang et al., 2016). There was also reported case in Ohio, 
US whereby a pregnant woman with community-acquired pyelonephritis whom urine culture 
revealed KPC-producing Klebsiella pneumoniae were successfully treated with combination 
of meropenem with fosfomycin and fosfomycin with cefepime (Khatri et al., 2015). 
Community- acquired NDM-1 were also been reported previously in elderly lady with cystitis 
living in France (Nordmann et al., 2012a). 
Besides that, the presence of carbapenemase resistant gene in the mobile genetic elements 
such as plasmid and transposon renders the ability of these resistant gene to cross between 
inter/intra species (Stokes and Gillings, 2011). It also confer resistant to other antimicrobials 
leading to pan-resistant CRE (Zowawi et al., 2015). There would be limited choice of 
antimicrobials and leading to higher mortality rate (40-50%) in invasive CRE infections 
(Patel et al., 2008). 
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2.10 Risk Factors for CRE 
The risk factors for CRE had been described previously in multiple studies. Exposure to 
health care and antimicrobials were among the most prominent risks for CRE (Schwaber et 
al., 2008; Hussein et al., 2009b). Exposure to antibiotics within 3 months was one of the 
independent risk factors for CRE (Marchaim et al., 2012). Use of several classes of 
antimicrobials has been associated with CRKP carriage or infection which include 
carbapenem (Patel et al., 2008; Hussein et al., 2009b), cephalosporins (Patel et al., 2008), 
fluoroquinolones (Schwaber et al., 2008), glycopeptides (Jiao et al., 2015; Ling et al., 2015), 
β-lactam plus β-lactam inhibitor and metronidazole (Swaminathan et al., 2013). Previous 
invasive procedure, diabetes mellitus, tracheostomy, solid tumor, urinary catheter insertion 
and antipseudomonal penicillin were identified as the risk factors for developing CRE 
infection in previously CRE colonizer patients (Borer et al., 2012).  
ICU admission, prior surgical procedure and presence of renal diseases has been among the 
risk factors for CRE colonization/infection (Kofteridis et al., 2014). ICU admission and acute 
kidney injury were also risk factors for CRE acquisition in Korea (Lee et al., 2016b). CRE 
infection/ colonization were also associated with mechanical ventilation, pulmonary diseases, 
days of antibiotic therapy and mean daily CRE colonization pressure in which patient were 
exposed (Swaminathan et al., 2013). The same study also revealed that odds of acquiring 
CRE increased by 4% per day of antibiotic therapy. 
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2.11 Mechanism of resistant in CRE 
Carbapenem resistant Enterobacteriaceae occurs from these two main mechanisms which are 
presence of carbapenemase genes that encodes for enzymes capable of degrading 
carbapenem, or overexpression of β-lactamases (AMP-C β-lactamases or ESBL) together 
with qualitative or/and quantitative deficiency of porin expression (Nordmann et al., 2012b). 
Porin are proteins which form as hydrophilic channels that allow uptake of essential nutrients 
for bacterial survival and also antibiotics. The type of porin that usually involve in antibiotic 
uptakes into the periplasmic space were OmpF and OmpC (Pagès et al., 2008). Any change 
in the type of porin presence in the outer membrane, loss of porin or modified porin can 
results in resistance to antibiotics. This type of carbapenem resistance usually associated with 
low level resistance of carbapenem.  
Carbapenemase production is usually associated with high level resistance of carbapenem. 
There are three Ambler molecular classes of β-lactamases involved in CP-CRE which are 
Ambler Class A, Class B and Class D. Class C β-lactamase are mainly involved with non-
CP-CRE. They are organized based on amino acid homology in the Ambler molecular 
classification. They are different in terms of active site of hydrolysing beta lactams and 
different resistance genes involved between classes. Class A, C and D need a serine residue 
in the active site in order to hydrolyse the β-lactams where else Class B enzymes required 
presence of zinc for the activity. These carbapenemase resistant genes resides in the mobile 
genetic elements such as transposons, integrons or plasmid causing potential spread to other 
isolates and from person to another person.  
2.11.1 Class A beta-lactamases 
Class A beta-lactamases with carbapenemase activity are encoded either on chromosomes or 
plasmids. Chromosomally-encoded enzymes are SME (Serratia marcescens enzyme), NMC 
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(non-metalloenzyme carbapenemase) and IMI (imipinem-hydrolyzing) beta-lactamases. 
These SME, NMC and IMI hydrolyse carbapenem, cephaloridine (1st generation 
cephalosporin), aztreonam and penicillin but inefficiently hydrolyse the 3rd generation 
cephalosporin (Queenan and Bush, 2007). SME has been found in few numbers of Serratia 
marcescens  in US (Queenan et al., 2000). Where else IMI and NMC were found from 
Enterobacter cloacae in US and France (Pottumarthy, 2003; Naas et al., 2012).    
KPC (Klebsiella pneumoniae carbapenemase) and GES (Guaiana-extended spectrum) were 
the two plasmid encoded Class A beta lactamases enzymes. GES were found in class 1 
integrons where else KPC were found in transposons elements in plasmid (Walther-
Rasmussen and Høiby, 2007). KPC were the most common carbapenemase enzymes seen in 
most part of US, although were commonly seen  in Klebsiella pneumoniae, other 
Enterobacteriaceae and non-Enterobacteriaceae like Pseudomonas aeruginosa and 
Acinetobacter spp were also have been reported harbouring KPC (Arnold et al., 2011).  
 
2.11.2 Class B beta-lactamases  
Class B beta-lactamases is also known as metallo-beta-lactamases (MBLs). They depend on 
zinc at their active site for hydrolysing beta-lactam drugs. They were inhibited by Ethylene 
Diamine Tetra Acetic Acid (EDTA) which was an ion chelator but were not inhibited by 
beta-lactamase inhibitor such as tazobactam, clavulanic acid and sulbactam (Juan et al., 
2008). They hydrolyze all beta-lactam drugs except for monobactams. The most common 
enzymes included in this class B beta-lactamases were New Delhi Metallo-beta-lactamase 
(NDM), Imipinemase Metallo-beta-lactamase (IMP), Verona integron-encoded Metallo-beta-
lactamase (VIM), Sao Paolo Metallo-beta-lactamase (SPM-1), German-imipinemase (GIM) 
and Seoul-imipinemase (SIM-1). VIM was first detected in northern Italy in 1997 (Lauretti et 
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al., 1999). Later on VIM was isolated in Turkey (Yildirim et al., 2013) and Russia 
(Shevchenko et al., 2012). SPM-1 were seen in Pseudomonas aeruginosa strain in Sao Paolo, 
Brazil (Carvalho et al., 2006). GIM-1 was isolated from Pseudomonas aeruginosa strain 
(Castanheira et al., 2004). GIM-1 has also been isolated from Enterobacter cloacae strain in 
German (Hamprecht et al., 2012). SIM-1 was isolated in Korea from Pseudomonas sp and 
Acinetobacter sp isolates. 
The first MBLs detected was IMP-1 from Pseudomonas aeruginosa in Japan in 1991 
(Watanabe et al., 1991). There after IMP has been spread to many other countries including 
Italy (Riccio et al., 2000),  US (Limbago et al., 2011), Australia (Sidjabat et al., 2015), China 
(Li et al., 2012) and Singapore (Koh et al., 2001) . The first IMP-4 was detected in 
Acinetobacter sp strain in Hong Kong (Chu et al., 2001). IMP-4 also has been detected in  
Citrobacter youngae strain in China (Hawkey et al., 2001). In Malaysia, the first bla-IMP7 was 
detected in Pseudomonas aeruginosa  from a peritoneal fluid taken from a child with 
peritonitis secondary to peritoneal dialysis (Ho et al., 2002). Subsequently bla-IMP4 and bla-
VIM2 was detected in imipinem resistant Pseudomonas aeruginosa strain in Malaysia 
(Khosravi et al., 2010).  
Although initially bla-IMP was seen mainly in Pseudomonas aeruginosa but it has been 
reported in Enterobacteriaceae (Leung et al., 2013) and Acinetobacter baumanii (Chu et al., 
2001). Six isolates (1.87%) of Carbapenem-Resistant Klebsiella pneumonia with bla-IMP4 
gene were detected in Malaysia (Hamzan et al., 2015). It indicates the spread of this resistant 
gene to other species. IMP has been found as gene cassette in class 1 integrons (Arakawa et 
al., 1995). It has been occasionally found in class 3 integrons (Shibata et al., 2003). Integrons 
were the genetic structures that have the ability to incorporate the gene cassette encoding the 
resistance gene using the site-specific recombination mechanism. IMP-4 share 90-99% amino 
acid identity with IMP-1 (Nordmann and Poirel, 2002). 
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The bla-NDM-1 was found in Klebsiella pneumoniae isolates from a Swedish who has been  
previously hospitalized in New Delhi, India (Yong et al., 2009). Since then, NDM-1 has 
spread to many continents except South America and Antarctica (Johnson and Woodford, 
2013). Later on NDM-1 has been discovered in seepage sample and drinking water sample in 
New Delhi (Walsh et al., 2011). It also has been found  in seepage water from river in 
Vietnam (Isozumi et al., 2012). NDM was unique compared to other MBLs and only 32.4% 
identical to VIM-1/VIM-2 which has the most similarity with NDM compared to other MBLs 
(Yong et al., 2009). Besides that, NDM was not found as gene cassette in class 1 integrons 
but was seen in the plasmid (Yong et al., 2009). Majority of other MBLs such as IMP, VIM, 
GIM and SIM were found in class 1 integrons. As for biochemical characteristics of NDM, it 
binds stronger to zinc ions compared to other MBLs and thus more susceptible to EDTA (Li 
et al., 2013). EDTA inactivates the zinc containing active site of the MBLs but it is toxic for 
clinical use. bla-NDM-1 (64%) was the most common carbapenemase gene seen in Singapore 
(Balm et al., 2013). 
 
2.11.3 Class D beta-lactamase 
Class D beta-lactamases also known as OXA-type-enzymes or oxacilinases can be divided 
into several subgroups which include OXA-48, OXA-51, OXA-58, OXA-143, OXA-24/40, 
OXA-23. Majority of them especially OXA-51, were seen on Acinetobacter spp, particularly 
Acinetobacter baumanii (Poirel et al., 2010; A Evans et al., 2013) except for OXA-48 where 
it has been isolated in Enterobacteriaceae (Glupczynski et al., 2012). This class D beta-
lactamase OXA-48 hydrolyse penicillin and carbapenem but spares the expanded-spectrum 
cephalosporin (Poirel et al., 2010). This OXA-48 strain Klebsiella pneumoniae was initially 
identified in Turkey  (Poirel et al., 2004) and then further spread to France (Levast et al., 
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2011),  Greece (Voulgari et al., 2013), Netherlands (Potron et al., 2011a) and South Africa 
(Brink et al., 2013). OXA-48 was still the most common carbapenemase enzymes in Turkey 
(Baran and Aksu, 2016). OXA-181 are different with OXA-48 by four amino acids 
substitution (Potron et al., 2011b). It was the second most common carbapenemase gene in 
Singapore (Balm et al., 2013). 
 
2.12 Clinical features of CRE 
CRE can cause either infection or colonization. There were several types of infections seen in 
CRE positive patient such as blood stream infection, ventilator associated pneumonia, urinary 
tract infection, intraabdominal infection (Gopi Patel et al., 2008; Nguyen et al., 2010; 
Marchaim et al., 2011; Tuon et al., 2016). There were 59% cases of symptomatic infection 
and 41% cases of asymptomatic colonization in 16 hospitals at South eastern United States 
(Thaden et al., 2014). Eight point eight percent (8.8%) of carriers later had a positive CRE 
clinical specimen and exposure to fluoroquinolone and metronidazole were to be associated 
with subsequent CRE clinical infection (Schechner et al., 2013). Thirty nine percent (39%) of 
CRE rectal carriage was still positive up to 1 year (Zimmerman et al., 2013). 
 Although Gram negative organisms rarely cause skin and soft tissue infections but they 
become more prevalent nowadays (Lee et al., 2005). There was reported cases of complicated 
skin and soft tissue infections caused by ESBL-producing Klebsiella pneumoniae (Perez, 
2007). CP-CRE caused by OXA-48 producing-Klebsiella pneumoniae has been reported to 
cause outbreak of surgical site infection in Spain (Paño-Pardo et al., 2012).  
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2.13 Laboratory diagnosis of CRE 
Revised interpretative criteria for carbapenems were first published in CLSI M-100-S20-U in 
June 2010. Previous Clinical and Laboratory Standards Institute (CLSI) guideline before June 
2010 has higher carbapenem breakpoints for imipinem, meropenem and ertapenem and has 
no breakpoints for doripenem. Where else CLSI guideline after June 2010 using a lower 
breakpoints for carbepenem and also include a breakpoint for doripenem. Details in the 
carbapenem break point were presented in the Table 2.1. 
Other phenotypic method for detection of CRE producing MBL include EDTA-double disc 
synergy test which look for synergistic inhibition zone and EDTA-combined disc test which 
look into difference in the zone of inhibition. Double disc synergy test shows highest 
sensitivity (100%) and specificity (96%) for detecting MBL in bla-VIM isolates that were 
tested and confirmed with molecular method (Galani et al., 2008). Where else another studies 
shows that combined disc test shows the highest sensitivity for detecting MBL in Egypt 
(94.6%) (El-Ghazzawy et al., 2016) and Nepal (100%) (Bora et al., 2014). However this 
combined disc test and double disc synergy test cannot be used in detecting class A and Class 
D carbapenemase. 
Carbapenemase detection is not necessarily done for diagnosis of CRE if the laboratories are 
using the newer breakpoint for carbapenemase MIC. However carbapenemase detection is 
important for infection control particularly when outbreak occurs or in terms of for 
understanding the epidemiology of CRE within geographical area. Certain more aggressive 
infection controls such as screening contacts and patient and staff cohorting can be reserved 
for those with CP-CRE  as this CP-CRE were believed to have a bigger potential of spread 
(CDC, 2016).  
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Modified Hodge Test (MHT) was found to have high sensitivity for detecting class A and 
class D carbapenemase but lower sensitivity (50%) and specificity (38.9%) for NDM (Girlich 
et al., 2012). Furthermore this test also subjected to false positive seen in cases of non- 
carbapenemase CRE (Carvalhaes et al., 2009). 31%-35% of non-carbapenemase-producing 
Enterobacter spp has been misclassified as carbapenemase producer by MHT (Chea et al., 
2015). However, MHT is still used in most laboratories as one of the method for confirmation 
of CP-CRE as it is a simple procedure and financially can be done in many limited resources 
laboratories.  
Other newer method for detecting carbapenemase include Carba NP test which used 
microtube method that detect the change in the  pH colour from red to yellow in the presence 
of carbapenemase and produce rapid results less than 2 hours. It can be used not only in 
Enterobacteriacea but also can be used to detect carbapenemases enzymes in Pseudomonas 
aeruginosa and Acinetobacter species. It has 100% specificity and positive predictive value 
but a lower sensitivity (72.5%) and negative predictive value (69.2%) and false negative were 
seen in OXA-48-like producers (Tijet et al., 2013). However, a revised method of Carba NP 
test showed 100% sensitivity and specificity for detection of all carbapenemase type of 
Enterobacteriacea and Pseudomonas aeruginosa isolates including OXA-48-like producers 
in comparison with PCR method (Dortet et al., 2014).  
Molecular method provides the most comprehensive review of the carbapenemase production 
of CRE. Specific genes involved can be determined which was important for epidemiological 
purpose and future plan of research. An example was the newer antibiotics ceftazidime-
avibactam which provide potential use of alternative treatment for KPC- producers but not 
for MBL (Sader et al., 2014). Therefore it is important of genotyping within geographical 
area. PCR method also can detect low level resistance CRE which were difficult to be 
detected in phenotypic test.  
